Karyopharm Strengthens Balance Sheet With $100 Million Financing To Extend Cash Runway Into 2026

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) on Wednesday announced comprehensive financing and capital structure transactions expected to provide the company with  $100 million of financial flexibility and additional capital, extending the cash runway into the second quarter of 2026.KPTI is among today’s weakest performers. See what is happening here.Karyopharm said it continues exploring potential financing and strategic alternatives to enhance liquidity and maximize value. Centerview Partners is the financ ...